We are live on ! Find out more
Janus Henderson Group

Janus Henderson Group Portfolio holdings

AUM $209B
1-Year Est. Return 37.72%
 

Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.

This Fund
S&P 500
This Quarter Est. Return
+9.55%
1 Year Est. Return
+37.72%
3 Year Est. Return
+117.83%
5 Year Est. Return
+153.46%
10 Year Est. Return
+660.32%
AUM
$234B
AUM Growth
+$14.6B
Cap. Flow
-$3.56B
Cap. Flow %
-1.52%
Top 10 Hldgs %
23.31%
Holding
1,725
New
172
Increased
741
Reduced
667
Closed
123

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$1.14B
2
MCHP icon
Microchip Technology
MCHP
+$535M
3
MRK icon
Merck
MRK
+$512M
4
BMY icon
Bristol-Myers Squibb
BMY
+$444M
5
ILMN icon
Illumina
ILMN
+$413M

Sector Composition

Rank Sector Weight
1 Technology 30.59%
2 Healthcare 18.35%
3 Consumer Discretionary 11.3%
4 Financials 10.45%
5 Communication Services 9.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TMCI icon
776
Treace Medical Concepts
TMCI
$260M
$21M 0.01%
+672,559
New +$21.4M
CRDF icon
777
Cardiff Oncology
CRDF
$63.6M
$21M 0.01%
3,151,167
+213,985
+7% +$1.81M
BRO icon
778
Brown & Brown
BRO
$25B
$20.9M 0.01%
393,551
-1,325
-0.3% -$68.1K
BMO icon
779
Bank of Montreal
BMO
$127B
$20.9M 0.01%
203,686
+13,154
+7% +$1.3M
TJX icon
780
TJX Companies
TJX
$178B
$20.5M 0.01%
303,556
-334,283
-52% -$22.8M
MAA icon
781
Mid-America Apartment Communities
MAA
$15.8B
$20.5M 0.01%
121,502
+29,805
+33% +$4.75M
BALY icon
782
Bally's
BALY
$720M
$20.3M 0.01%
375,830
+371,337
+8,265% +$20.9M
NTRS icon
783
Northern Trust
NTRS
$22.2B
$20.3M 0.01%
175,789
+123,204
+234% +$14.1M
ADV icon
784
Advantage Solutions
ADV
$542M
$20.3M 0.01%
75,162
+36,292
+93% +$11.2M
QRVO icon
785
Qorvo
QRVO
$8.09B
$20.1M 0.01%
102,653
+17,689
+21% +$3.26M
COGT icon
786
Cogent Biosciences
COGT
$6.95B
$19.8M 0.01%
2,438,201
+155,073
+7% +$1.31M
EFX icon
787
Equifax
EFX
$22B
$19.8M 0.01%
82,550
+5,456
+7% +$1.22M
AEM icon
788
Agnico Eagle Mines
AEM
$71.9B
$19.7M 0.01%
325,895
+169,397
+108% +$11.3M
SRDX
789
DELISTED
Surmodics
SRDX
$19.5M 0.01%
359,981
-13,289
-4% -$729K
ENPH icon
790
Enphase Energy
ENPH
$4.79B
$19.4M 0.01%
105,452
-116,645
-53% -$17.1M
FMTX
791
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
$19.3M 0.01%
776,845
-69,378
-8% -$1.86M
GH icon
792
Guardant Health
GH
$19B
$19.1M 0.01%
154,033
-82,829
-35% -$11.1M
AMH icon
793
American Homes 4 Rent
AMH
$12.2B
$19M 0.01%
489,963
+418,472
+585% +$15.5M
ABCM
794
DELISTED
Abcam PLC
ABCM
$19M 0.01%
998,982
-153,182
-13% -$3.05M
SJR
795
DELISTED
Shaw Communications Inc.
SJR
$19M 0.01%
655,769
-407,632
-38% -$11.8M
IVV icon
796
iShares Core S&P 500 ETF
IVV
$871B
$19M 0.01%
44,123
+10,245
+30% +$4.29M
ATO icon
797
Atmos Energy
ATO
$29.9B
$18.9M 0.01%
197,050
+79,958
+68% +$8.02M
ITUB icon
798
Itaú Unibanco
ITUB
$91.6B
$18.8M 0.01%
4,311,946
-434,555
-9% -$1.75M
EXR icon
799
Extra Space Storage
EXR
$32.2B
$18.8M 0.01%
114,859
+54,926
+92% +$8.23M
MTD icon
800
Mettler-Toledo International
MTD
$28.1B
$18.7M 0.01%
13,472
-5,791
-30% -$7.47M

Similar funds

Janus Henderson Group's Q2 2021 Portfolio in Review

As of Q2 2021, Janus Henderson Group held 1,725 positions worth $234B, up 6.7% from $219B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Janus Henderson Group's Q2 2021 filing shows 172 new, 741 increased, 667 reduced and 123 closed positions. Its largest new stake was Centessa Pharmaceuticals: 5,680,933 shares worth $120M. The largest sale was Apple, an estimated $1.14B.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Janus Henderson Group's largest Q2 2021 buy was Centessa Pharmaceuticals: 5,680,933 shares worth $120M.
  • Janus Henderson Group added most to United Parcel Service in Q2 2021, an estimated $428M increase.
  • Janus Henderson Group's biggest Q2 2021 reduction was Apple, cutting an estimated $1.14B.
  • Janus Henderson Group fully exited PRA Health Sciences, Inc. in Q2 2021, selling an estimated $368M.
  • Janus Henderson Group's ten largest holdings make up 23% of its $234B portfolio in Q2 2021.
  • Janus Henderson Group opened 172 new positions and closed 123 in Q2 2021.
  • Janus Henderson Group's portfolio value rose 6.7% quarter-over-quarter to $234B.

Based on Janus Henderson Group's 13F filing for Q2 2021, filed 16 Aug 2021.